INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title:
TO DEVELOP AN ALTERNATE EFFICIENT MICROPARTICULATE SYSTEM(S) FOR ANTITUBERCULAR DRUG(S) BY ENGINEERING THE SURFACE OF PARTICLES TO REACH MYCOBACTERIUM INTRACELLULARLY
Due to its status as the biggest infectious disease killer globally, along with HIV infection, tuberculosis (TB) continues to be a serious global health concern (HIV). A important opportunistic illness among people with a high incidence of AIDS is tuberculosis (TB). Mycobacterium tuberculosis (MTB), which causes TB, is a lethal infectious illness that primarily affects the respiratory system. Meningitis, circulatory tuberculosis, lymphatic tuberculosis, genitourinary tuberculosis, bones, and joints are other major public health concerns caused by MTB. Pharmacokinetic event showed that an experimental carrier's drug plasma profile is significantly influenced by the physico-chemical properties of the polymer. Tmax for RIF (Free) was found to be 2.890.31hr, whereas Tmax for the chitosan ascorbate formulation was found to be 13.250.01hr and 16.410.81hr for C3S3P4T2R and C3S3P4T2I, respectively. The results make it abundantly apparent that MMAD did not significantly change when the formulations were kept in a refrigerator. Although the MMAD significantly varied when the formulations were held at room temperature, it nevertheless stayed within the range of respirable particles that alveolar macrophages can effectively absorb. The amount of drug that has been incorporated into the formulation determines its therapeutic impact; as a result, the residual drug content was tracked and contrasted with the results from the stability testing phase. The results suggested that the conjugation with ligand greatly decreased the leaching of medication from formulations. This finding may be related to the bulky group on the surface of microspheres, which may have prevented some drug leakage.
Keywords:
Rifampicin, Chitosan, antitubercular drug, In-vivo study
Cite Article:
"TO DEVELOP AN ALTERNATE EFFICIENT MICROPARTICULATE SYSTEM(S) FOR ANTITUBERCULAR DRUG(S) BY ENGINEERING THE SURFACE OF PARTICLES TO REACH MYCOBACTERIUM INTRACELLULARLY", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.7, Issue 12, page no.a625-a641, December-2022, Available :http://www.ijnrd.org/papers/IJNRD2212085.pdf
Downloads:
000118744
ISSN:
2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Facebook Twitter Instagram LinkedIn